theory clinical_47_8
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  PARP :: "entity ⇒ bool"
  DSBs :: "entity ⇒ bool"
  SSBreakRepair :: "entity ⇒ bool"
  CollapsedReplicationForks :: "event ⇒ bool"
  Function :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  Prevent :: "event ⇒ bool"
  LeadTo :: "event ⇒ bool"
  LossBRCA2 :: "entity ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  GenomicInstability :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Involve :: "event ⇒ bool"
  DefectiveHRR :: "event ⇒ bool"
  TrappingPARP1 :: "entity ⇒ bool"
  NHEJ :: "entity ⇒ bool"
  Toxicity :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  Indicate :: "event ⇒ bool"
  Reliance :: "event ⇒ bool"
  ErrorProneNHEJ :: "event ⇒ bool"
  InhibitionPARP :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  Occurrence :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Rely :: "event ⇒ bool"

(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks. *)
axiomatization where
  explanation_1: "∃x y z w e1 e2 e3 e4 e5. PARPInhibitors x ∧ PARP y ∧ DSBs z ∧ SSBreakRepair w ∧ CollapsedReplicationForks e5 ∧ Function e1 ∧ Agent e1 x ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e3 ∧ Agent e3 x ∧ Patient e3 z ∧ Prevent e4 ∧ Agent e4 x ∧ Patient e4 w ∧ LeadTo e5 ∧ Agent e5 x"

(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. LossBRCA2 x ∧ CancerDevelopment y ∧ GenomicInstability z ∧ Drive e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ Involve e2 ∧ Agent e2 z ∧ DefectiveHRR e2"

(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3. TrappingPARP1 x ∧ DSBs y ∧ NHEJ z ∧ Toxicity w ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Increase e2 ∧ Agent e2 x ∧ Patient e2 w ∧ Indicate e3 ∧ Agent e3 x ∧ Reliance e3 ∧ ErrorProneNHEJ e3"

(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks. *)
axiomatization where
  explanation_4: "∃x y z e1 e2. InhibitionPARP x ∧ PARPInhibitors y ∧ DSBs z ∧ Lead e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Occurrence e2 ∧ Agent e2 z"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DSBs y ∧ SSBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Rely e3 ∧ Agent e3 x ∧ DefectiveHRR e3 ∧ ErrorProneNHEJ e3"
proof -
  (* From the premise, we have the known information about PARP inhibitors. *)
  from asm have "PARPInhibitors x" by auto
  (* Explanation 1 provides that PARP inhibitors cause double-strand breaks and prevent single-strand break repair. *)
  (* Logical relations Implies(A, B) and Implies(A, C) support this. *)
  then obtain y z e1 e2 where "DSBs y ∧ SSBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z" sledgehammer
  (* Explanation 2 and its logical relations show that genomic instability involves defective homologous recombination repair. *)
  (* Explanation 3 and its logical relations show reliance on error-prone non-homologous end joining for DNA repair. *)
  then obtain e3 where "Rely e3 ∧ Agent e3 x ∧ DefectiveHRR e3 ∧ ErrorProneNHEJ e3" <ATP>
  then show ?thesis <ATP>
qed

end
